Suppr超能文献

相似文献

2
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Am J Respir Cell Mol Biol. 2012 Mar;46(3):355-64. doi: 10.1165/rcmb.2010-0155OC. Epub 2011 Oct 20.
6
DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Am J Physiol Cell Physiol. 2022 Jul 1;323(1):C133-C144. doi: 10.1152/ajpcell.00067.2022. Epub 2022 May 18.
7
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
PLoS One. 2017 Oct 18;12(10):e0186615. doi: 10.1371/journal.pone.0186615. eCollection 2017.

引用本文的文献

1
Phase 2 study design and analysis approach for BBT-877: an autotaxin inhibitor targeting idiopathic pulmonary fibrosis.
BMJ Open Respir Res. 2025 May 22;12(1):e003038. doi: 10.1136/bmjresp-2024-003038.
2
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).
Expert Rev Clin Pharmacol. 2024 Sep;17(9):817-835. doi: 10.1080/17512433.2024.2396121. Epub 2024 Aug 27.
3
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.
Eur Respir Rev. 2024 Jun 12;33(172). doi: 10.1183/16000617.0015-2024. Print 2024 Apr.
5
Functional meniscus reconstruction with biological and biomechanical heterogeneities through topological self-induction of stem cells.
Bioact Mater. 2024 Mar 11;36:358-375. doi: 10.1016/j.bioactmat.2024.03.005. eCollection 2024 Jun.
7
Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases.
Biomedicines. 2024 Jan 8;12(1):124. doi: 10.3390/biomedicines12010124.
9
Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.
Int J Mol Sci. 2023 Aug 7;24(15):12524. doi: 10.3390/ijms241512524.
10
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis.
Cell Chem Biol. 2023 Sep 21;30(9):1169-1182.e8. doi: 10.1016/j.chembiol.2023.06.014. Epub 2023 Jul 11.

本文引用的文献

2
Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.
FASEB J. 2013 Apr;27(4):1749-60. doi: 10.1096/fj.12-219634. Epub 2013 Jan 11.
4
Molecular mechanisms in progressive idiopathic pulmonary fibrosis.
Annu Rev Med. 2013;64:265-76. doi: 10.1146/annurev-med-042711-142004. Epub 2012 Sep 27.
5
Lysophospholipid receptor activation of RhoA and lipid signaling pathways.
Biochim Biophys Acta. 2013 Jan;1831(1):213-22. doi: 10.1016/j.bbalip.2012.09.004. Epub 2012 Sep 15.
6
TGF-β activation and lung fibrosis.
Proc Am Thorac Soc. 2012 Jul;9(3):130-6. doi: 10.1513/pats.201201-003AW.
7
The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Proc Am Thorac Soc. 2012 Jul;9(3):111-6. doi: 10.1513/pats.201203-023AW.
8
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.
Am J Respir Cell Mol Biol. 2012 Nov;47(5):566-74. doi: 10.1165/rcmb.2012-0004OC. Epub 2012 Jun 28.
9
Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung.
Cell Tissue Res. 2012 Jun;348(3):491-503. doi: 10.1007/s00441-012-1385-9. Epub 2012 Mar 22.
10
Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-β1-dependent pathway.
Cell Signal. 2012 Jun;24(6):1241-50. doi: 10.1016/j.cellsig.2012.02.009. Epub 2012 Feb 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验